Lupin Ltd (LUPIN) — Announcement | 8 September 2026

8 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Lupin to present at Kotak and J.P. Morgan investor conferences

💡 Investor Takeaway

These events offer investors direct access to management for discussing Lupin's pipeline and strategy.

Lupin Ltd announced its participation in two upcoming investor events: the Kotak Healthcare Conference on September 17, 2026, and the J.P. Morgan India Conference on September 21, 2026, both scheduled as in-person group meetings. The filing confirms the company will present using materials already available on its website or stock exchanges, with no new financial details disclosed. These events provide direct engagement opportunities with analysts and institutional investors ahead of upcoming operational milestones.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Ltd (LUPIN)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹94,274.49 CrP/E: 16.6ROE: 24.6%ROCE: 27.9%Div Yield: 0.87%

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"When will Lupin share its next earnings guidance?""What pipeline milestones are targeted for H2 2026?""How does Lupin's R&D spend compare to peers?"

Ask AI Free →

📊 More LUPIN filings

🔴 Announcement — 28 September 2026Lupin announced that its U.S. subsidiary received tentative FDA approval for a novel apixaban oral s...
Announcement — 28 September 2026Lupin Ltd announced that its insider trading window will close on October 1, 2026, and remain shut u...
🔴 Corporate Action — 21 September 2026Lupin announced on September 21, 2026, the allotment of 24,111 fully paid-up equity shares of ₹2 eac...
🔴 Announcement — 4 September 2026Lupin announced that the U.S. FDA approved its ANDA for Modafinil Tablets USP 100 mg and 200 mg, mar...
🔴 Announcement — 28 August 2026Lupin Limited announced it received an ESG rating of Crisil ESG 69 and a Core ESG rating of Crisil C...

See all LUPIN filings →

🔥 Also filed on 8 September 2026

500357Rama Paper Mills LtdAnnual Report 514028Rajkamal Synthetics LtdAnnual Report INDIANORGFutura Polyesters LtdFinancial Results UYFINCORPU. Y. Fincorp LtdAnnual Report APOLLOApollo Micro Systems LtdAnnual Report 544201Dindigul Farm Product LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.